Therefore, to reveal the clinical relevance of β-catenin destruction complex key components (GSK3β, APC, RACK1, and AXIN) with β-catenin protein in GC, we then examined the expression of them in 155 cases of GC surgically resected specimens, which were divided into low-expression group and high-expression group. The gene discussed is GSK3B; the disease is gastric cancer.